South Dakota Investment Council Increases Holdings in Teleflex Incorporated (NYSE:TFX)

South Dakota Investment Council increased its holdings in shares of Teleflex Incorporated (NYSE:TFXFree Report) by 16.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,230 shares of the medical technology company’s stock after purchasing an additional 1,300 shares during the quarter. South Dakota Investment Council’s holdings in Teleflex were worth $1,643,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Janus Henderson Group PLC increased its holdings in Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after acquiring an additional 147,147 shares during the last quarter. FMR LLC grew its position in shares of Teleflex by 70.1% during the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock valued at $66,650,000 after purchasing an additional 111,086 shares in the last quarter. Point72 Asset Management L.P. increased its holdings in shares of Teleflex by 31.2% in the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after purchasing an additional 96,958 shares during the last quarter. Parkman Healthcare Partners LLC purchased a new stake in shares of Teleflex in the third quarter worth about $23,778,000. Finally, Ceredex Value Advisors LLC boosted its stake in Teleflex by 64.6% during the third quarter. Ceredex Value Advisors LLC now owns 199,975 shares of the medical technology company’s stock valued at $49,458,000 after buying an additional 78,500 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Trading Up 0.2 %

Shares of TFX opened at $175.43 on Monday. The company’s fifty day simple moving average is $176.98 and its 200-day simple moving average is $207.23. The company has a market cap of $8.15 billion, a P/E ratio of 34.88, a P/E/G ratio of 1.73 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a twelve month low of $165.62 and a twelve month high of $249.90.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Truist Financial reduced their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Royal Bank of Canada decreased their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $246.00.

View Our Latest Research Report on TFX

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Stories

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.